SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-008499
Filing Date
2021-04-12
Accepted
2021-04-12 09:55:02
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 980610
2 ex31-1.htm EX-31.1 17034
3 ex31-2.htm EX-31.2 17102
4 ex32-1.htm EX-32.1 6513
  Complete submission text file 0001493152-21-008499.txt   5050581

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE brtx-20200930.xml EX-101.INS 902988
6 XBRL SCHEMA FILE brtx-20200930.xsd EX-101.SCH 54677
7 XBRL CALCULATION FILE brtx-20200930_cal.xml EX-101.CAL 62494
8 XBRL DEFINITION FILE brtx-20200930_def.xml EX-101.DEF 217800
9 XBRL LABEL FILE brtx-20200930_lab.xml EX-101.LAB 405852
10 XBRL PRESENTATION FILE brtx-20200930_pre.xml EX-101.PRE 326100
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 21819655
SIC: 8090 Services-Misc Health & Allied Services, NEC